These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24815362)

  • 1. Progress in the characterization of bio-functionalized nanoparticles using NMR methods and their applications as MRI contrast agents.
    López-Cebral R; Martín-Pastor M; Seijo B; Sanchez A
    Prog Nucl Magn Reson Spectrosc; 2014 May; 79():1-13. PubMed ID: 24815362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising approaches in using magnetic nanoparticles in oncology.
    Mikhaylov G; Vasiljeva O
    Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and magnetic resonance imaging: The value of immunoliposomes.
    Kozlowska D; Foran P; MacMahon P; Shelly MJ; Eustace S; O'Kennedy R
    Adv Drug Deliv Rev; 2009 Dec; 61(15):1402-11. PubMed ID: 19796661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging.
    Zhou L; Zheng X; Gu Z; Yin W; Zhang X; Ruan L; Yang Y; Hu Z; Zhao Y
    Biomaterials; 2014 Aug; 35(26):7666-78. PubMed ID: 24929618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT; Kostarelos K
    Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear assemblies of magnetic nanoparticles as MRI contrast agents.
    Corr SA; Byrne SJ; Tekoriute R; Meledandri CJ; Brougham DF; Lynch M; Kerskens C; O'Dwyer L; Gun'ko YK
    J Am Chem Soc; 2008 Apr; 130(13):4214-5. PubMed ID: 18331033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
    Miguel OB; Gossuin Y; Morales MP; Gillis P; Muller RN; Veintemillas-Verdaguer S
    Magn Reson Imaging; 2007 Dec; 25(10):1437-41. PubMed ID: 17566686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast agents for MRI.
    Shokrollahi H
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4485-97. PubMed ID: 24094150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes.
    Hu F; Zhao YS
    Nanoscale; 2012 Oct; 4(20):6235-43. PubMed ID: 22971876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
    Winter PM; Cai K; Chen J; Adair CR; Kiefer GE; Athey PS; Gaffney PJ; Buff CE; Robertson JD; Caruthers SD; Wickline SA; Lanza GM
    Magn Reson Med; 2006 Dec; 56(6):1384-8. PubMed ID: 17089356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional Nanotherapeutics with All-in-One Nanoentrapment of Drug/Gene/Inorganic Nanoparticle.
    Jia HZ; Wang W; Zheng DW; Wang X; Yu WY; Li SY; Zhuo RX; Zhao YF; Feng J; Zhang XZ
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):6784-9. PubMed ID: 26962876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging.
    Ju KY; Lee JW; Im GH; Lee S; Pyo J; Park SB; Lee JH; Lee JK
    Biomacromolecules; 2013 Oct; 14(10):3491-7. PubMed ID: 23987128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo simulation and theory of proton NMR transverse relaxation induced by aggregation of magnetic particles used as MRI contrast agents.
    Vuong QL; Gillis P; Gossuin Y
    J Magn Reson; 2011 Sep; 212(1):139-48. PubMed ID: 21807538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
    Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
    Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents.
    Lartigue L; Hugounenq P; Alloyeau D; Clarke SP; Lévy M; Bacri JC; Bazzi R; Brougham DF; Wilhelm C; Gazeau F
    ACS Nano; 2012 Dec; 6(12):10935-49. PubMed ID: 23167525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core/shell nanoparticles in biomedical applications.
    Chatterjee K; Sarkar S; Jagajjanani Rao K; Paria S
    Adv Colloid Interface Sci; 2014 Jul; 209():8-39. PubMed ID: 24491963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatible KMnF3 nanoparticular contrast agent with proper plasma retention time for in vivo magnetic resonance imaging.
    Liu ZJ; Song XX; Xu XZ; Tang Q
    Nanotechnology; 2014 Apr; 25(15):155101. PubMed ID: 24642699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of multifunctional magnetic nanoparticles.
    McCarthy JR; Kelly KA; Sun EY; Weissleder R
    Nanomedicine (Lond); 2007 Apr; 2(2):153-67. PubMed ID: 17716118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of proton relaxation for enzyme-manipulated, multicomponent gold-magnetic nanoparticle chains.
    Jaganathan H; Gieseck RL; Hudson K; Kellogg M; Ramaswamy AK; Raver KE; Smith T; Vacchiano AN; Wager A; Ivanisevic A
    Chemphyschem; 2010 Dec; 11(17):3664-72. PubMed ID: 21077085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.